ENTITY

Silexion Therapeutics (SLXN US)

3
Analysis
Health Care • United States
Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company developing proprietary RNA interference (RNAi) therapies for KRAS-driven cancers. The company is offering shares and warrants in a best-efforts offering to advance its pre-clinical and clinical studies and for general corporate purposes.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x